Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor

被引：0
|
作者：
Ying Lin
Bo Yu
Haifeng Sun
Hongyu Zhang
Zhihuang Hu
Yao Zhang
Zhenhua Wu
Si Sun
Xinmin Zhao
Hui Yu
Xianghua Wu
Yuan Li
Jialei Wang
Huijie Wang
机构：
[1] Fudan University Shanghai Cancer Center,Department of Thoracic Medical Oncology
[2] Shanghai Medical College,Department of Oncology
[3] Fudan University,Third Department of Medical Oncology
[4] Shaanxi Provincial Cancer Hospital Affiliated to Medical College of Xi’an Jiaotong University,Department of Thoracic Surgery
[5] Zhongshan Hospital,Department of Pathology
[6] Fudan University,undefined
[7] Fudan University Shanghai Cancer Center,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Thoracic SMARCA4-deficient undifferentiated tumor; SMARCA4-deficient thoracic sarcomatoid tumor; SMARCA4-deficient thoracic sarcoma; Immune checkpoint inhibitor; LRP1B;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8663 / 8671
页数：8
相关论文
共 50 条
  • [1] Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
    Lin, Ying
    Yu, Bo
    Sun, Haifeng
    Zhang, Hongyu
    Hu, Zhihuang
    Zhang, Yao
    Wu, Zhenhua
    Sun, Si
    Zhao, Xinmin
    Yu, Hui
    Wu, Xianghua
    Li, Yuan
    Wang, Jialei
    Wang, Huijie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 8663 - 8671
  • [2] Promising efficacy of immune-checkpoint inhibitor with chemotherapy for SMARCA4-deficient thoracic sarcomatoid tumors.
    Lin, Ying
    Zhang, Yao
    Hu, Zhihuang
    Wu, Xianghua
    Wang, Jialei
    Wang, Huijie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor
    Shinno, Yuki
    Yoshida, Akihiko
    Masuda, Ken
    Matsumoto, Yuji
    Okuma, Yusuke
    Yoshida, Tastuya
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Yatabe, Yasushi
    Ohe, Yuichiro
    CLINICAL LUNG CANCER, 2022, 23 (05) : 386 - 392
  • [4] Thoracic SMARCA4-deficient undifferentiated tumor
    Jiapeng Jiang
    Zhixin Chen
    Jiali Gong
    Na Han
    Hongyang Lu
    Discover Oncology, 14
  • [5] Thoracic SMARCA4-deficient undifferentiated tumor
    Jiang, Jiapeng
    Chen, Zhixin
    Gong, Jiali
    Han, Na
    Lu, Hongyang
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [6] Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
    Gantzer, Justine
    Davidson, Guillaume
    Vokshi, Bujamin
    Weingertner, Noelle
    Bougouin, Antoine
    Moreira, Marco
    Lindner, Veronique
    Lacroix, Guillaume
    Mascaux, Celine
    Chenard, Marie-Pierre
    Bertucci, Francois
    Davidson, Irwin
    Kurtz, Jean-Emmanuel
    Sautes-Fridman, Catherine
    Fridman, Wolf H.
    Malouf, Gabriel G.
    ONCOLOGIST, 2022, 27 (06): : 501 - 511
  • [7] SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report
    Utsumi, Takahiro
    Taniguchi, Yohei
    Noda, Yuri
    Fukai, Mari
    Kibata, Kayoko
    Murakawa, Tomohiro
    THORACIC CANCER, 2022, 13 (15) : 2264 - 2266
  • [8] SMARCA4-deficient undifferentiated thoracic tumor: A case report
    Kwon, Hee Jung
    Jang, Min Hye
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (11)
  • [9] THORACIC SMARCA4-DEFICIENT UNDIFFERENTIATED TUMOR PRESENTING WITH HYPERCALCEMIA
    Puthenpura, Max
    Nathani, Avantika R.
    Chhabria, Mamta S.
    CHEST, 2022, 162 (04) : 1708A - 1708A
  • [10] Recent updates in thoracic SMARCA4-deficient undifferentiated tumor
    Nambirajan, Aruna
    Jain, Deepali
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2021, 38 (05) : 83 - 89
12345